Kassirer Asset Management’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Kassirer Asset Management’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-120,000	Closed	-$803K	–	95
2017 Q2	$803K	Buy	+120,000	New	+$755K	0.58%	46

Kassirer Asset Management's NVET Position: Q3 2017 in Review

Kassirer Asset Management sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 120,000 shares — an estimated $803K sold.

Kassirer Asset Management first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $803K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

Kassirer Asset Management reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Kassirer Asset Management sold 120,000 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $803K.
Kassirer Asset Management first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
Kassirer Asset Management's Nexvet Biopharma plc Ordinary Shares position peaked at $803K in Q2 2017.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Kassirer Asset Management's 13F filing for Q3 2017, filed 6 Nov 2017.